Kimia Farma’s Loss Due to Expired Vaccines
Kimia Farma and the holding of state-owned pharmaceutical companies have an excess stock of vaccines that are nearing their expiration date. The state could suffer losses.
Retno Sulistyowati
October 16, 2023
KIMIA Farma is enjoying a good time in business. In the first semester of 2023, the state-owned pharmaceutical company made an operating profit of Rp236.29 billion (around US$15.7 million). This achievement stands in contrast to the situation in the first semester of last year, when Kimia Farma suffered an operational loss of Rp15.67 billion (US$1 million). Kimia Farma Chief Executive Officer (CEO) David Utama said that the company could rec
...